Sildenafil stimulates aqueous humor turnover in rabbits
Autor: | Lawrence J. Alvarez, Aldo C. Zamudio, Oscar A. Candia |
---|---|
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
genetic structures Anterior Chamber Sildenafil Fluorophotometry Piperazines Sildenafil Citrate Article Aqueous Humor Cellular and Molecular Neuroscience chemistry.chemical_compound Ciliary body Internal medicine Paracentesis Animals Medicine Ingestion Sulfones Fluorescein medicine.diagnostic_test business.industry Ciliary Body Blood flow Phosphodiesterase 5 Inhibitors eye diseases Sensory Systems Ophthalmology medicine.anatomical_structure Endocrinology chemistry Purines Regional Blood Flow Rabbits sense organs Trabecular meshwork business |
Zdroj: | Experimental Eye Research. 111:67-70 |
ISSN: | 0014-4835 |
DOI: | 10.1016/j.exer.2013.03.016 |
Popis: | Sildenafil citrate increases ocular blood flow and accelerates the rate of anterior chamber refilling after paracentesis. The latter effect could have resulted from a reduction in outflow facility or from an increase in aqueous humor (AH) production. In this study, we used scanning ocular fluorophotometry to examine the effects of sildenafil on AH turnover, and thus, AH production in eyes of live normal rabbits. For this, the rate of aqueous humor flow (AHF) was quantified with a commercially available fluorophotometer that measured the rate of fluorescein clearance from the anterior segment, which predominantly occurs via the trabecular meshwork. After ≈ 2 hrs of control scans to determine the baseline rate of AHF, the rabbits were fed 33 mg of sildenafil and allowed ≈ 45 min for the drug to enter the systemic circulation. Thereafter, fluorescence scans were retaken for an additional 90–120 min. Sildenafil ingestion increased AHF by about 36%, from 2.31 μL/min to 3.14 μL/min (P< 0.001, as two-tailed paired data, n= 20 eyes). This observation indicates that sildenafil citrate, which is a phosphodiesterase type-5 inhibitor currently marketed as a vasodilator (e.g., Viagra, Revatio), stimulates AHF in rabbits. Our results seem consistent with reports indicating that the drug dilates intraocular arteries and augments intraocular vascular flow. These physiological responses to the agent apparently led to increased fluid entry into the anterior chamber. As such, the drug might have utility in patients with ocular hypotony resulting from insufficient AH formation. |
Databáze: | OpenAIRE |
Externí odkaz: |